Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Sleep therapy may boost cancer pill adherence

NCT ID NCT05887297

Symptom relief Sponsor: University of Strathclyde Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tested whether a 4-week online sleep therapy program (CBT for insomnia) could help breast cancer survivors take their daily hormone-blocking pills more regularly. 35 women with insomnia who sometimes missed their medication took part. The goal was to see if improving sleep also improved medication habits and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
cognitive behavioural therapy for insomnia (CBT-I)
What this could lead to
If it works, this could point toward a way to help breast cancer survivors stick with their long-term medication by improving their sleep.
What could go wrong
This is a small pilot study with only 35 people, so results may not apply to everyone. It relies on self-reported adherence, which can be inaccurate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

35 people

The number who actually took part.

Started

Mar 2023

Finished

Apr 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosed with breast cancer * Aged 18 or over * Currently prescribed endocrine therapy medication * Experience symptoms of insomnia * Self-reported nonadherent to ET medication (e.g. forgetting to take, or deliberately taking a break from medication) * Proficient in English language * Access to videoconferencing Exclusion Criteria: * Undertaking shift work (i.e., irregular or night shifts) * Pregnancy or breastfeeding * Other unstable physical or mental health problem (including substance misuse) * Received CBT-I within past 12 months * Received chemotherapy or radiotherapy within past 4 weeks

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adherence, medication are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm insomnia Medication Adherence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adherence, medication Breast cancer Insomnia Quality of life Survivorship

Contacts and locations

Locations

  • University of Strathclyde

    Glasgow, County (Optional), G1 1XQ, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.